Available on-demand: Real world insight into diabetes management – The Diabetes Debate

Now available on demand (free to access) – originally broadcast on October 29th 2014.
Non-adherence to self-management regimens in diabetes is globally a widespread, costly and ultimately life threatening issue.

Reasons for non-adherence are complex as the nature of the condition involves adherence to  lifestyle, medication and diet changes, which individuals at times can find difficult to accept and adjust to. It is important to consider that the factors that influence each individual’s ability to self manage are often very different and can equally affect patient outcomes, making this a globally recognised problem.

Working in collaboration with self-management and health psychology experts, Atlantis Healthcare, this pharmaphorum webinar will combine direct insights from leading patient advocates (and diabetes patients themselves) Kerri Sparling, type 1 diabetes patient and Editor of Six Until Me and Simon O’Neill, type 1 diabetes patient and Director of Health Intelligence and Professional Liaison, Diabetes UK.

The 25 minute presentation and 30 minute panel discussion considers patient insights from our recent ‘managing diabetes in the real world’ tweetchat. With additional expertise provided by Atlantis Healthcare’s Dr Sinead Ni Mhurchadha. Health Psychology Specialist and Charles Mackinnon, Director of NHS Partnerships and non-Executive Director to Manchester AHSN, to give a real world view on the unique solutions needed to effectively manage adherence and support self-management .

The webinar will also look at how healthcare stakeholders (pharma, payers and healthcare professionals) can support type 1 and type 2 to manage their condition, understand better the challenges these patients face and how we can help support improved outcomes for diabetes patients worldwide.

Combining both presentation and debate you can access this online event here: click here  or on the webinar widget below.

 

Charles Mackinnon, Director of Partnerships, Atlantis Healthcare & Non-Executive Director to Manchester AHSN

Charles is Director of partnerships at Atlantis Healthcare enabling collaborative working to deliver patient centred support programmes. He has consulted to a number of start-up digital healthcare businesses looking to utilize technology as an enabler of delivering better patient outcomes.
In November 2013 Charles was appointed Non-Executive Director of Greater Manchester Academic Health Science Network.

 

 

Dr Sinead Ni Mhurchadha. Health Psychology Specialist, Atlantis Healthcare

As a Health Psychology Specialist for Atlantis Healthcare in the UK, Sinéad supports a multidisciplinary team by designing the psychological underpinning of patient support programmes in a broad array of health areas in particular, type 1 and type 2 diabetes. The ultimate aim of these programmes is to promote adherence amongst patients to prescribed treatment and self-management regimens. Sinéad is motivated by a strong desire to equip patients with the necessary skills so that they can adjust to diabetes in the long term and successfully manage their condition.
She is a Chartered Psychologist and Associate Fellow with the British Psychological Society and a Registered Health Psychologist with the Psychological Society of Ireland.

Simon O’Neill Director of Health Intelligence and Professional Liaison, Diabetes UK
Simon qualified from St Thomas’ Hospital, London as a registered nurse in 1989 and specialised in paediatrics at Guy’s Hospital in 1991. Following several years working in both general and renal paediatrics, he moved to Diabetes UK in 1995 as a nurse care adviser. Nineteen years later he is still there, although now as Director of Health Intelligence and Professional Liaison. As Director he is responsible for ensuring Diabetes UK produces accurate and up to date information and advice on all aspects of diabetes care, based on the latest evidence. Working closely with healthcare professional colleagues, he also advises on the charity’s policies and positions. He has had type 1 diabetes for 22 years.

Kerri Sparling, Patient Advocate and Editor of Six Until Me

Kerri Sparling is the creator and author of Six Until Me, one of the first and most widely read diabetes patient blogs, reaching a global audience of patients, caregivers, and industry. Outside of her blog, Kerri’s work can be found at diaTribe, Animas, and in diabetes outreach like JDRF’s Countdown magazine, in addition to her extensive diabetes YouTube channel. Kerri is well-versed in social media and its influence on patients. Diagnosed in 1986 she has had type 1 diabetes for over 27 years, managing her condition and living her life by the mantra “Diabetes doesn’t define me, but it helps explain me.”

Dr Paul Tunnah, CEO, pharmaphorum

 

Paul Tunnah is CEO & Founder of pharmaphorum media, which facilitates productive engagement for pharma, bringing healthcare together to drive medical innovation. It combines industry-leading content and social media engagement services with the globally recognised news, information and insight portal pharmaphorum.com, working with pharmaceutical companies, service providers and broader healthcare organisations to help communicate their thought leadership and connect them with relevant stakeholders.

 

 

* When you click to register for this webinar you will be taken to a website run by BrightTalk who host the webinar and gather your registration data.
This data may then be passed to pharmaphorum media limited, and in turn passed to the company(ies) we are partnering with to bring you the webinar. This data may be used by us and them for occasional marketing purposes. It will not be shared with any further third parties.
By clicking to register for this webinar you give consent for any data you provide to be used in this way.
If at any point you no longer wish to be contacted based on the information you provide during the registration for this webinar, please send an email to info@pharmaphorum.com requesting that your information is deleted in accordance with the General Data Protection Regulation.